The presence of drug in control samples during toxicokinetic investigations—A Novartis perspective

Authors:
  • MKMaryelle Kolopp
    Maryelle Kolopp
  • FPFrançoise Pommier
    Françoise Pommier
  • MSMelanie Scheiwiller
    Melanie Scheiwiller

Abstract
No abstract available

This publication has 1 reference indexed in Scilit: